Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corp (NQ: LQDA )

9.015 -0.195 (-2.12%)
Streaming Delayed Price Updated: 10:42 AM EDT, Sep 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 70,410
Open 9.200
Bid (Size) 9.000 (4)
Ask (Size) 9.030 (1)
Prev. Close 9.210
Today's Range 9.015 - 9.210
52wk Range 5.710 - 16.99
Shares Outstanding 76,793,694
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Performance

YTD
-21.81%
-21.81%
1 Month
-26.17%
-26.17%
3 Month
-34.91%
-34.91%
6 Month
-33.76%
-33.76%
1 Year
+27.69%
+27.69%

More News

Read More
Liquidia to Present at Upcoming Investor Conferences
From Liquidia Corporation
Via GlobeNewswire
These Analysts Cut Their Forecasts On Liquidia
Via Benzinga
Why Liquidia Corporation Shares Are Moving Lower Monday
Via Benzinga
LIQUIDIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Liquidia Corporation (LQDA)
From Kirby McInerney LLP
Via Business Wire
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
From Liquidia Corporation
Via GlobeNewswire
Expert Ratings For Liquidia
Via Benzinga
Expert Outlook: Liquidia Through The Eyes Of 5 Analysts
Via Benzinga
Jim Cramer Praises PayPal CEO Alex Chriss: 'Financial Techs Have Come Back In Style'
Via Benzinga
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Forecasting The Future: 5 Analyst Projections For Liquidia
Via Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
Via Investor's Business Daily
LQDA Investors Have Opportunity to Join Liquidia Corporation Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
From Liquidia Corporation
Via GlobeNewswire
LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
From Liquidia Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.